0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Cardiovascular medicine

Buy Now

Cardiac Arrhythmias: New Therapeutic Drugs and Devices - Proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA October 4 and 5, 1984 (Paperback, Softcover reprint of the original 1st ed. 1985) Loot Price: R4,251
Discovery Miles 42 510
Cardiac Arrhythmias: New Therapeutic Drugs and Devices - Proceedings of the Symposium on New Drugs and Devices, held at...

Cardiac Arrhythmias: New Therapeutic Drugs and Devices - Proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA October 4 and 5, 1984 (Paperback, Softcover reprint of the original 1st ed. 1985)

J. Morganroth, E.Neil Moore

Series: Developments in Cardiovascular Medicine, 47

 (sign in to rate)
Loot Price R4,251 Discovery Miles 42 510 | Repayment Terms: R398 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Donate to Against Period Poverty

In summary, there are many animal models that are useful in selecting new antiarrhythmic drugs. The selection of which model is most idea depends upon precisely what question is being asked. The large number of experimental models used to evaluate antiarrhythmic compounds points out the inability of anyone model to define the probability of antiarrhythmic efficacy in man. It has therefore become standard practice to utilize a batter of animal models for the evaluation of new antiarrhythmic agents. Each model has its own advantages and disadvantages and it is necessary to understand each model fully in oder to evaluate experimental findings and apply them to clinical settings. We believe that the availability of the chronic myocardial infarction ventricular tachyarrhythmia model provides 1) an excellent opportunity to more precisely understand arrhythmia mechanisms, 2) to develop new techniques such as signal averaging for evaluating late low level potentials identifying hearts at high risk of sudden death 3) to identify new antifibrillatory drugs versus drugs that are effective primarily against PVC's and ventricular tachycardia 4) to identify new surgical techniques to eliminate VT/VF, and 5) to evaluate new pacing modalities including implantable cardioverters. Although all animal models are wrong, many are very useful in furthering our knowledge directed at decreasing the distressingly high mortality from heart disease. NORMAL HtART TACHYCMDIA HtART , .. '" \ I I I I I I I I I .

General

Imprint: Springer-Verlag New York
Country of origin: United States
Series: Developments in Cardiovascular Medicine, 47
Release date: October 2011
First published: 1985
Editors: J. Morganroth • E.Neil Moore
Dimensions: 235 x 155 x 20mm (L x W x T)
Format: Paperback
Pages: 356
Edition: Softcover reprint of the original 1st ed. 1985
ISBN-13: 978-1-4612-9626-3
Categories: Books > Medicine > Clinical & internal medicine > Cardiovascular medicine
Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
LSN: 1-4612-9626-9
Barcode: 9781461296263

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners